Lista de obras -

AI-10DISTINCT EGFR SIGNALING IN GLIOBLASTOMA: WILD-TYPE EGFR PROMOTES INVASION WHILE EGFRvIII DRIVES PROTOTYPICAL SFK c-SRC ACTIVATION TO FOSTER ANGIOGENESIS.

artículo científico publicado en 2014

ATPS-59IMPROVING EFFICACY OF BEVACIZUMAB TREATMENT IN GLIOBLASTOMA BY TARGETING HIF1 ALPHA.

artículo científico publicado en 2015

Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways.

artículo científico publicado en 2017

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

artículo científico publicado en 2011

Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?

artículo científico publicado en 2014

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas

artículo científico publicado en 2014

Cardiometabolic risk: leg fat is protective during childhood.

artículo científico publicado en 2015

EGFL7 enhances surface expression of integrin αβ to promote angiogenesis in malignant brain tumors

artículo científico publicado en 2018

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis

artículo científico publicado en 2013

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

artículo científico publicado en 2016

Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells

artículo científico publicado en 2015

Federated learning enables big data for rare cancer boundary detection

Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.

artículo científico publicado en 2015

Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier

scientific article published on 29 August 2019

Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma

artículo científico publicado en 2017

MAPPING THE GLIOBLASTOMA METABOLOME AFTER BEVACIZUMAB THERAPY BY 13C6-GLUCOSE METABOLOMIC FLUX ANALYSIS.

artículo científico publicado en 2014

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma

scientific article published on 25 March 2016

Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies.

artículo científico publicado en 2014

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

scientific article published on 03 October 2020

Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors

artículo científico publicado en 2021

Spatially regularized estimation of the tissue homogeneity model parameters in DCE-MRI using proximal minimization

scientific article published on 17 July 2019

Subtraction of subcutaneous fat to improve the prediction of visceral adiposity: exploring a new anthropometric track in overweight and obese youth.

artículo científico publicado en 2016

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.

scientific article published on 30 May 2013

Lista de obras de

AI-10DISTINCT EGFR SIGNALING IN GLIOBLASTOMA: WILD-TYPE EGFR PROMOTES INVASION WHILE EGFRvIII DRIVES PROTOTYPICAL SFK c-SRC ACTIVATION TO FOSTER ANGIOGENESIS.

ATPS-59IMPROVING EFFICACY OF BEVACIZUMAB TREATMENT IN GLIOBLASTOMA BY TARGETING HIF1 ALPHA.

Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas

Cardiometabolic risk: leg fat is protective during childhood.

EGFL7 enhances surface expression of integrin αβ to promote angiogenesis in malignant brain tumors

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells

Federated learning enables big data for rare cancer boundary detection

Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.

Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier

Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma

MAPPING THE GLIOBLASTOMA METABOLOME AFTER BEVACIZUMAB THERAPY BY 13C6-GLUCOSE METABOLOMIC FLUX ANALYSIS.

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma

Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies.

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors

Spatially regularized estimation of the tissue homogeneity model parameters in DCE-MRI using proximal minimization

Subtraction of subcutaneous fat to improve the prediction of visceral adiposity: exploring a new anthropometric track in overweight and obese youth.

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.